Search
for
Sort by
Research 301–330 of 1000+
- Abstracts of 28th Year Annual Meeting of Turkish Society of Neuroradiology with International Participation, Conrad Istanbul Bosphorus, Istanbul, Turkey, February 15-17, 2019
- Inconsistent effects of surgical and chemical castration on arterial baroreceptor dysfunction and cardiac and brainstem inflammation in endotoxic rats
- Endocrinology Overview RSS
- Endocrine Disorders and Infertility
- SAT378 Unusual Case of Hirsutism From Prolactinoma Induced Dihydrotestosterone Elevation
- Secondary Amenorrhea in a 15-year-old Girl
- Projekt "Sztutowo czy Stutthof? Oswajanie krajobrazu kulturowego" Perspektywa antropologiczna
- Hair loss and hyperprolactinemia in women
- Polycystic Ovary Syndrome in Adolescents
- Clinicopathologic and Morphologic Analysis of the Adrenal Gland in Pomeranians with Non-Illness Alopecia
- Insight into the pathogensis of polycystic ovarian syndrome
- Delayed Puberty
- P-50 WE KNOW YOU ARE THERE: MISSING MASS
- ANALÝZA KORTIZOLU VO VLASOCH – BIOMARKER AKTIVÁCIE HPA OSI
- Developmental origin of polycystic ovary syndrome - a hypothesis
- The use of hair cortisol for the assessment of stress in animals
- Pelvic ultrasound and color Doppler findings in different isosexual precocities
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance
- Update on Drugs Used to Treat Endocrine Diseases in Small Animals
- Androgens
- Reproductive System, Male
- Hormonal Induction of Feather Pigmentation in Ptarmigan
- Local Actions of Thyrotropin-Releasing Hormone Regulate Hair Color
- Modelling androgen synthesis and action during human sexual differentiation
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- The Skin POMC System (SPS): Leads and Lessons from the Hair Follicle
- 8 Hair follicles and associated glands as androgen targets
- Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes